English: Description of Goods 2-cyano-3-morpholinoacrylamide; 2-ethoxy-5-fluoropyrimidin-4(1H)-one; 2-guanidinothiazol-4-ylmethyl carbamimidothioate dihydrochloride; 2-iodo-4-(1H-1,2,4-triazol-1-ylmethyl)aniline; 20-oxopregna-5,16-dien-3-beta-yl acetate; 21-chloro-9-beta,11-beta-epoxy-17-hydroxy-16-alpha-methyl-pregna-1,4diene-3,20-dione; 3'-acetyl-4'-hydroxybutyranilide; 3'-azido-3'-deoxy-5'-O-tritylthymidine; 3'-O-mesyl-5'-O-tritylthymidine; 3,4-(methylenedioxy)phenol; 3-(4-chloro-1,2,5-thiadiazol-3-yl)pyridine; 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1-methylpyridinium iodide; 3-(4-nitrophenyl)-L-alanine; 3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxooctahydro-1H-inden-4-yl]propionic acid; 3-[(E)-2-(7-chloro-2-quinolyl)vinyl]benzaldehyde; 3-[(S)-3-(L-alanylamino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4dihydro-1,8-naphthyridine-3-carboxylic acid hydrochloride; 3-[2-(3-chlorophenyl)ethyl]-2-pyridyl 1-methyl-4-piperidyl ketone hydrochloride; 3-[2-(3-chlorophenyl)ethyl]pyridine-2-carbonitrile; 3-aminopyrazole-4-carboxamide hemisulfate; 3-beta-hydroxy-5-alpha-spirostan-12-one; 3-chloroformyl-o-tolyl acetate; 3-isopropoxy-5-methoxy-N-(1H-tetrazol-5-yl)benzo[b]thiophene-2carboxamide, sodium salt; 3-isopropoxy-5-methoxy-N-(1H-tetrazol-5-yl)benzo[b]thiophene-2carboxamide--1H-imidazole (1:1); 3-isopropoxy-5-methoxy-N-(1H-tetrazol-5-yl)benzo[b]thiophene-2carboxamide; 3-methyl-7-(phenylacetamido)-3-cephem-4-carboxylic acid; 3-oxopregn-4-ene-21,17-alpha-carbolactone; 4'-[2-(dimethylamino)ethoxy]-2-phenylbutyrophenone; 4'-demethylepipodophyllotoxin; 4-(2,2,3,3-tetrafluoropropoxy)cinnamonitrile; 4-(piperazin-1-yl)-2,6-bis(pyrrolidin-1-yl)pyrimidine; 4-[2-(cyclopropylmethoxy)ethyl]phenol; 4-carboxy-4-phenylpiperidinium p-toluenesulfonate; 4-ethyl-2,3-dioxopiperazine-1-carbonyl chloride; 4-nitrophenyl thiazol-5-ylmethyl carbonate hydrochloride; 5'-O-tritylthymidine; 5,6-dimethoxyindan-1-one; 5-(1-methyl-4-piperidyl)-5H-dibenzo[a,d]cyclohepten-5-ol hydrochloride; 5-[(2-aminoethyl)amino]-2-(2-diethylaminoethyl)-2H-[1]benzothiopyrano[4,3,2-cd]indazol-8-ol; 5-[(benzofuran-2-ylcarbonyl)amino]indole-2-carboxylic acid; 5-[(R)-(2-aminopropyl)]-2-methoxybenzenesulfonamide; 5-amino-2,4,6-triiodoisophthaloyl dichloride; 5-chloro-1-methyl-4-nitroimidazole; 5-chloro-2-(3-methyl-4H-1,2,4-triazol-4-yl)benzophenone; 5-chloro-2-[3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4yl]benzophenone; 5-ethyl-4-(2-phenoxyethyl)-4H-1,2,4-triazol-3(2H)-one; 5-methanesulfonamidoindole-2-carboxylic acid;
French: Dénomination des marchandises Concentré intermédiaire issu d'un milieu de fermentation d'Escherichia coli génétiquement modifié, contenant de l'interféron humain alpha-2b, destiné à la fabrication de médicaments de la position 30.02; Concentrés intermédiaires issus d'un milieu de fermentation de Micromonospora inyoensis, destinés à la fabrication des antibiotiques sisomicine (DCI) et nétilmicine (DCI); Concentrés intermédiaires issus d'un milieu de fermentation de Micromonospora purpurea, destinés à la fabrication des antibiotiques sulfate de gentamicine (DCIM) et isépamicine (DCI); 2,3-dihydro-1H-pyrrolizine-1-carboxylate d'isopropyle; isopropyl[2-(pipérazine-1-yl)-3-pyridyl]amine; L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-Lleucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-Lleucyl-L-leucyl-L-leucyl-L-leucyl-L-lysine; bis[(2,3-dihydro-1,5-diméthyl-3-oxo-2-phényl-1H-pyrazole-4-yl) méthylamino]méthanesulfonate de magnésium; méso-N-benzyl-3-nitrocyclopropane-1,2-dicarboximide; (2R,3S)-2,3-époxy-3-(4-méthoxyphényl)propionate de méthyle; (2R,3S)-3-benzamido-2-hydroxy-3-phénylpropionate de méthyle; (4-nitrophényl)-L-alaninate de méthyle; 1H-1,2,4-triazole-3-carboxylate de méthyle; 2-(3-nitrobenzylidène)-3-oxobutyrate de méthyle; 7-[(3RS)-3-hydroxy-5-oxocyclopent-1-ényl]heptanoate de méthyle; di(acétate) de N,N'-dibenzyléthylènediammonium; 7,7-dioxyde de N-(5,6-dihydro-6-méthyl-2-sulfamoyl-4H-thiéno[2,3b]thiopyranne-4-yl)acétamide; N-(9-acétyl-6-oxo-6,9-dihydro-1H-purine-2-yl)acétamide; N-(benzyloxycarbonyl)-L-valine; N-(benzyloxycarbonyl)-S-phényl-L-cystéine; N-(tert-butyl)-3-méthylpyridine-2-carboxamide; acide N-[(R)-2-({(R)-2-[(2-adamantyloxycarbonyl)amino]-3-(1H-indole-3yl)-2-méthyl-1-oxopropyl}amino)-1-phényléthyl]succinamique--1désoxy-1-méthylamino-D-glucitol (1:1); N-[2-isopropylthiazole-4-ylméthyl(méthyl)carbamoyl]-L-valine; acide N-{5-[(1,4-dihydro-2-méthyl-4-oxoquinazoline-6-ylméthyl) méthylamino]-2-thénoyl}-L-glutamique; omega-conotoxine M VIIA; (2R,5R,6S)-6-[(R)-1-hydroxyéthyl]-3,7-dioxo-1-azabicyclo[3.2.0]heptane2-carboxylate de p-nitrobenzyle; bis{3-[1-(3,4-diméthoxybenzyl)-6,7-diméthoxy-1,2,3,4-tétrahydro-2isoquinolyl]propionate} de pentaméthylène--acide oxalique (1:2); chloroformiate de pentyle; 1-(1-hydroxyéthyl)-5-méthoxy-2-oxo-1,2,5,6,7,8,8a,8b-octahydroazéto[2,1-a]isoindole-4-carboxylate de potassium; purine-6(1H)-one; quinuclidine-3-ol; (Z)-2-(2-aminothiazole-4-yl)-2-méthoxyiminothioacétate de S(benzothiazole-2-yle); 4-[2-(5-méthylpyrazine-2-carboxamido)éthyl]benzènesulfonamide de sodium; [(1S,2S)-1-benzyl-2,3-dihydroxypropyl]carbamate de tert-butyle; [(1S,3S,4S)-4-amino-1-benzyl-3-hydroxy-5-phénylpentyl]carbamate de tert-butyle; [(4R,6R)-6-(cyanométhyl)-2,2-diméthyl-1,3-dioxolanne-4-yl]acétate de